Dana Yaacov-Garbeli - 19 Apr 2024 Form 4/A Insider Report for Entera Bio Ltd. (ENTX)

Role
Chief Financial Officer
Signature
/s/ Dana Yaacov-Garbeli
Issuer symbol
ENTX
Transactions as of
19 Apr 2024
Net transactions value
$0
Form type
4/A
Filing time
02 Aug 2024, 16:31:06 UTC
Date Of Original Report
23 Apr 2024
Previous filing
25 Apr 2023
Next filing
18 Jul 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENTX Ordinary Shares, par value NIS 0.0000769 per share Award $0 +30,151 +53% $0.000000 86,731 19 Apr 2024 By A2Z Counseling Ltd. F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ENTX Stock Option (right to buy) Award $0 +130,000 $0.000000 130,000 19 Apr 2024 Ordinary Shares, par value NIS 0.0000769 per share 130,000 $1.99 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represent a grant of stock-settled restricted stock units. The restricted stock units vest ratably on a quarterly basis over a one-year period that began on April 19, 2024.
F2 On April 23, 2024, the reporting person filed a Form 4 which inadvertently reported that the reporting person's ordinary shares and restricted stock units are held directly.
F3 These shares are owned by A2Z Counseling Ltd. of which the reporting person owns a 33.33% interest and has effective control over voting and disposition of the shares. The reporting person disclaims beneficial ownership of the securities held by A2Z Counseling Ltd., except to the extent of her pecuniary interest therein, if any, and this report shall not be deemed an admission that she is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
F4 The options vest over a three-year period with 33% of the options vesting on April 19, 2025, the first anniversary of the vesting commencement date. The remaining options vest ratably on a quarterly basis over the remaining two-year period.